These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7655826)

  • 1. Aspects of the design and delivery of microparticles for vaccine applications.
    Jenkins PG; Coombes AG; Yeh MK; Thomas NW; Davis SS
    J Drug Target; 1995; 3(1):79-81. PubMed ID: 7655826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
    Jiang W; Gupta RK; Deshpande MC; Schwendeman SP
    Adv Drug Deliv Rev; 2005 Jan; 57(3):391-410. PubMed ID: 15560948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines.
    Jones DH; Partidos CD; Steward MW; Farrar GH
    Behring Inst Mitt; 1997 Feb; (98):220-8. PubMed ID: 9382743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.
    Zhao A; Rodgers VG
    J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral delivery of micro-encapsulated DNA vaccines.
    Jones DH; Clegg JC; Farrar GH
    Dev Biol Stand; 1998; 92():149-55. PubMed ID: 9554269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
    Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T
    J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
    Gupta RK; Chang AC; Siber GR
    Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant.
    Jain S; O'Hagan DT; Singh M
    Expert Rev Vaccines; 2011 Dec; 10(12):1731-42. PubMed ID: 22085176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum.
    Kohane DS; Tse JY; Yeo Y; Padera R; Shubina M; Langer R
    J Biomed Mater Res A; 2006 May; 77(2):351-61. PubMed ID: 16425240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly (DL-lactide-co-glycolide) based delivery systems for vaccines and drugs.
    Dhiman N; Dutta M; Khuller GK
    Indian J Exp Biol; 2000 Aug; 38(8):746-52. PubMed ID: 12557904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
    Benny O; Duvshani-Eshet M; Cargioli T; Bello L; Bikfalvi A; Carroll RS; Machluf M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):768-76. PubMed ID: 15701867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solvent evaporation processes for the production of controlled release biodegradable microsphere formulations for therapeutics and vaccines.
    Cleland JL
    Biotechnol Prog; 1998; 14(1):102-7. PubMed ID: 9496674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology.
    Emami J; Hamishehkar H; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Mirzadeh H; Fakhari A; Nokhodchi A
    J Microencapsul; 2009 Feb; 26(1):1-8. PubMed ID: 18465287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New advances in vaccine delivery systems.
    Eldridge JH; Staas JK; Chen D; Marx PA; Tice TR; Gilley RM
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):16-24; discussion 25. PubMed ID: 8303306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lectins and microparticles for enhanced oral vaccination.
    Lavelle EC
    Methods; 2006 Feb; 38(2):84-9. PubMed ID: 16406570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of Japanese encephalitis virus vaccine loaded poly(L-lactide-co-glycolide) microspheres for oral immunization.
    Khang G; Cho JC; Lee JW; Rhee JM; Lee HB
    Biomed Mater Eng; 1999; 9(1):49-59. PubMed ID: 10436853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
    Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G
    Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained delivery of lidocaine into the cochlea using poly lactic/glycolic acid microparticles.
    Horie RT; Sakamoto T; Nakagawa T; Tabata Y; Okamura N; Tomiyama N; Tachibana M; Ito J
    Laryngoscope; 2010 Feb; 120(2):377-83. PubMed ID: 19950377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.